(Q37248396)

19 August 2017

1 reference

title

CTLA-4 blockade with monoclonal antibodies in patients with metastatic cancer: surgical issues (English)

1 reference

19 August 2017

1 reference

1 reference

3

Vernon K Sondak

1 reference

19 August 2017

Giao Q Phan

1

1 reference

19 August 2017

Jeffrey S Weber

series ordinal

2

1 reference

19 August 2017

publication date

21 August 2008

1 reference

Annals of Surgical Oncology

19 August 2017

published in

1 reference

19 August 2017

volume

15

1 reference

19 August 2017

issue

11

1 reference

19 August 2017

page(s)

3014-3021

1 reference

Results of a phase II clinical trial of 2 doses and schedules of CP-675,206, an anti-CTLA4 monoclonal antibody, in patients (pts) with advanced melanoma

19 August 2017

cites work

1 reference

18 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1200/JCO.2007.25.18_SUPPL.3000

Durable responses and long-term progression-free survival observed in a phase II study of MDX-010 alone or in combination with dacarbazine (DTIC) in metastatic melanoma

1 reference

18 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1200/JCO.2005.23.16_SUPPL.7525

Biochemical and immunologic correlates of clinical response in a combination trial of the GM-CSF-gene transduced allogeneic prostate cancer immunotherapy and ipilimumab in patients with metastatic hormone-refractory prostate cancer (mHRPC)

1 reference

18 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1200/JCO.2007.25.18_SUPPL.5120

Identifiers

DOI

10.1245/S10434-008-0104-Y

1 reference

Dimensions Publication ID

19 August 2017

1006883342

0 references

1 reference